Obesity Medication Guidelines: Evidence-Based A...

By João L. Carapinha

January 15, 2026

Obesity Medication Guidelines: ADA's Evidence-Based Framework The American Diabetes Association (ADA) obesity medication guidelines, recently published, outline medications...
Bausch Health’s Strategic Growth in Latin American Pharmaceuticals Thro...
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Navigating Novo Nordisk Board Changes: Leadership for Growth and Strategy
Sanofi Insulin Savings: Your Comprehensive Guide for 2025
Addressing GLP-1 Access Inequity: Lessons from HIV/AIDS Mobilization
Oral Semaglutide Benefits: EMA Approves First Oral GLP-1 RA with Cardiovascul...
Insights on GLP-1 Therapy in Bariatric Surgery Patients
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
Building a Better Ecosystem for Digitally Enabled Diabetes Care in Europe
Comprehensive Review of Type 2 Diabetes Treatment and Diagnosis Strategies